Access, quality and costs of prenatal diagnosis

Luis A Izquierdo1, Steven Berkshire

  • 1Regis University College of Professional Studies, Healthcare Services Administration, Westminster, CO, USA. izqui611@regis.edu

Insights

Prenatal diagnosis screening offers significant benefits for detecting birth defects and genetic disorders. However, healthcare system barriers, including cost and language, limit access, leading to increased healthcare expenses and health inequalities.

Area of Science:

  • Medical Genetics
  • Public Health
  • Healthcare Economics

Background:

  • Birth defects affect 2-5% of newborns, contributing significantly to pediatric hospital admissions and mortality.
  • Advances in prenatal diagnosis and genetics enable early detection and treatment of in utero genetic disorders.
  • Prenatal screening is crucial for all pregnant women to assess risks of birth defects and genetic conditions.

Purpose of the Study:

  • To highlight the importance of prenatal diagnosis screening for all pregnant women.
  • To identify barriers hindering access to prenatal diagnostic services.
  • To analyze the economic implications of limited access to prenatal care and diagnosis.

Main Methods:

  • Review of existing literature on prenatal diagnosis and healthcare access.
  • Analysis of economic impact of prenatal diagnosis on healthcare systems.
  • Examination of psychosocial, financial, and linguistic barriers to healthcare services.

Main Results:

  • Prenatal diagnosis can save healthcare systems millions of dollars.
  • Barriers like cost, insurance, and language significantly impede access to prenatal diagnosis.
  • Lack of access leads to cost shifting and escalates overall healthcare costs.

Conclusions:

  • The current healthcare system exhibits inequalities in delivering prenatal diagnostic services.
  • Existing barriers to access, quality, and cost create an inefficient and flawed system.
  • Addressing these barriers is essential for equitable and cost-effective prenatal care.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Documentation of Nursing Diagnosis01:10

Documentation of Nursing Diagnosis

The nurse documents nursing diagnoses and enters them into the patient record. The identified patient's nursing diagnosis is either written out with a plan of care or entered into the electronic health record.
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters assessment...